Singapore Markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) BTC-USD
66,937.78 -33.31 (-0.05%) CMC Crypto 200
1,368.42 -5.43 (-0.40%)
ADCT May 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:36PM EDT
| Previous close | 1.7500 |
| Open | 1.2500 |
| Bid | 1.2500 |
| Ask | 3.9000 |
| Strike | 2.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.2500 - 1.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
GlobeNewswireADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on Monday, May 20, 2024 at 2:00 p.m. ET. A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website ir.adctherapeutics.com. A replay of the webcast will be
Simply Wall St.ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations
ADC Therapeutics ( NYSE:ADCT ) First Quarter 2024 Results Key Financial Results Revenue: US$18.1m (down 4.9% from 1Q...
GuruFocus.comInsider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29,731 shares of the company.
© 2024 Yahoo. All rights reserved.